Axonal navigation
during development requires that cues present in the extracelllar environment be capable of modifying the structure of the cone in a dynamic way. Protein kinase C (PKC) has long been suspected to be one of the multiple molecular relays present in the terminal structure of the developing axon and involved in the transduction of extracellular signals. The latter proposal is, however, based on the use of drugs or of protocols leading to pleiotropic and often nonspecific effects. In the present study, we have taken advantage of the discovery of a peptide capable of translocating across biological membranes and to accumulate in the cytoplasm and nucleus of cells in culture, to internalize a highly specific peptidic inhibitor of PKC. We demonstrate that linking the two peptides (vector and PKC inhibitor) allows the internalization of the latter in live cells, specifically inhibits PKC and provokes a rapid modification of growth cone morphology.
This set of data thus establishes that a peptidic inhibitor of PKC activity, once internalized, provokes a change in growth cone morphology, reminiscent of the collapse phenotype.
In addition, the present study describes a new efficient and harmless way to introduce pharmacologically active substances in neural cells in culture.
[Key words: neurons, growth cones, cultures, protein kinase C, motility, collapse] During neurite elongation, growth cones interact with several molecules present in their environment. Such interactions require the presence of specific receptors capable of transducing extracellular molecular signals within the cells. In addition to positive signals (Tessier-Lavigne and Plazcek, I99 I ; Tessier-Lavigne et al., 1994) . growth cone navigation also implies negative re- sponses to extracellular cues (Bentley and O'Connor, 1994; Kaprielian and Patterson, 1994) . Repulsive behaviors, arrest and/or collapse, have been observed in several models, leading to the characterization of extracellular and trans-membrane proteins that provoke growth cone collapse (Tessier-Lavigne, 1994) . Molecules, mediating positive and negative effects, probably act in concert with extracellular matrix components (see Letourneau et al., 1994 , for review) and the combined effects are transduced within the growth cone. Although the exact transducing mechanisms are not known they are likely to involve multiple transmembrane receptors and second messenger pathways.
Several data suggest that protein kinase C (PKC), a family of serine-threonine kinases activated by phorbol ester, participate in the regulation of growth cone morphology and motility. The evidence, however, remains circumstantial, since it is based on the presence of PKC isoenzymes within growth cones (Campenot et al., 1994) , on desensitization protocols, and on the use of lipophilic PKCs antagonists such as staurosporine and H7 (Smalheiser, 1993; Doherty et al., 1994; Qian et al., 1994) . These protocols are very indicative but suffer from the lack of specificity of the drugs (Rasouly et al., 1992; Jalava et al.. 1993 ) and of unknown pathways triggered by long term treatment with phorbol ester.
PKC is a family of isozymes functionally sub-divided into three classes: cPKC (cu, PI, PII, y) are Ca"/diacylglycerol (DAG)/phosphatidyl-serine (PS) sensitive, nPKC (6, l , n, 8) are only activated by the DAG/PS pathway and not by CaL ', and aPKC ($, A) are the least characterized and not activated by Cal* nor DAG (for review see Tanaka and Nishizuka, 1994; Azzi et al., 1992; Dekker and Parker, 1994) . An N-terminus domain [ PKC,,~,,] corresponding to a pseudosubstrate sequence is common to all known PKC isozymes (Barja et al., 1994) . Under resting conditions, this domain occupies the catalytic site of the enzyme, thereby acting as a natural inhibitor.
Several strategies have thus been developed to internalize the PKC pseudosubstrate peptide (House and Kemp. 1990 ; Kemp, I99 I). These strategies require either membrane perturbation (addition of lipids, permeabilization) or intracellular injection (O'Brian et al., 1990; Eichholtz et al., 1993; Ward and O-Brian, 1993; Hvalby et al., 1994) .
The goal of the present study was to develop a new protocol to introduce the pseudosubstrate peptide into neurons in culture and to study the effects of specific PKC inhibition on growth cone behavior. The internalization protocol is based on the property of the third helix of the homeodomain of Antennapedia to translocate across biological membranes (Derossi et al., 1994) . We show that PKC pseudosubstrate linked to the peptide vector is internalized by live neurons, leading to specific inhibition of PKC activity and to a rapid modification of growth cone morphology.
Materials and Methods
Peptide synthesis. Peptide synthesis was carried out at a 0.1 mmol scale (ABI model 431A synthesizer) starting from a 4-methylbenzhydrylamine (MBHA) resin. All N-cw-ter-butyloxycarbonyl (N-a-Boc) amino acids, in lo-fold excess, were assembled using dicyclohexylcarbodiimide (DCC) and 1-hydroxybenzotiazole (HOBt) as coupling agents. BocCys-(NPyS)OH was coupled directly to the peptide as the last (N-ter) amino acid. Peptides were cleaved from the resin by anhydrous fluorhydric acid (HF) and purified by preparative reverse phase HPLC (Applied Biosystems), using a 10 X 250 nm Brownlee column (Aquapore Octyl, 300 A pore size) and acetonitrile gradients in aqueous 0.1% TFA (trifluoracetic acid). The purity of collected fractions was established by analytical isocratic separation (HPLC, Waters Associate) on lichrosphere 10 RP-8 columns (Merck) and in 0.25 M triethylammonium phosphate pH 3.0 (buffer A) and acetonitrile. Peptide molecular weights were determined by electrospray ionization mass spectrometry in the laboratory of Dr. J. C. Tabet (UniversitC P et M. Curie, Paris).
Biotinylation of the PKCi peptide was performed using NHS-biotin (Pierce reagent). Free NHS-biotin was deactivated by incubation with 100 mu glycine for 2 hr at 4°C. Uncoupled deactivated pAntp,,.,, and biotinylated-PKCi peptides used in control experiments were treated with a 10 X molar ratio of cysteine in order to reduce the N-terminal NPyS-cysteinyl residue of both peptides.
Coupling reaction.
The pAntp,,-,, peptide for use as a vector was dissolved in deionized and degased water and treated with an equimolar ratio of tris-(2-carboxyethyl)phosphine,hydrochloride (TCEP, Molecular Probes) in order to generate a free thiol group. An equimolar ratio of NPyS-PKCi was added and the mixture was incubated at 37°C for 1 hr.
The yield of the reaction, estimated by SDS-PAGE followed by Coomasie staining, was routinely above 50%. The coupled product (VPKCi) was further purified byOHPLC on a 10 X 250 nm Brownlee column (Aquapore Octyl, 300 A pore size) and lyophylized.
Cell culture. Cortical neurons from El6 rat fetuses were prepared and cultured as previously described (Lafont et al., 1993) . Briefly, dissociated cells were plated onto D,L-polyomithine (1.5 pg/ml) coated plastic dishes at a density of IO4 cells per well in 24 multiwell plates (morphometric analysis) or of lo5 cells per well in 96 well microtitration dishes (ELISA). Astrocytes were prepared as described in Lafont et al. (1992) . To visualize the internalized peptides, neurons were grown for 24 hr and incubated for 1 hr at 37°C with the peptides prediluted in 100 ~1 of culture medium, washed twice in phosphate buffer (PBS), once in PBS plus 500 mM NaCl, rinsed in PBS, and fixed in EtOW acetic acid (9:1, by volume) for 5 min at -20°C. Biotin was revealed using FITC-streptavidin complex (Amersham) diluted lOO-fold in PBS plus 0.1% Tween 20. For immunocytochemistry, the cells were fixed (1 hr at room temperature) with paraformaldehyde (4% in PBS), rinsed in PBS-glycine 5 ells pH 7.4, incubated for 1 hr at 37°C with a polyclonal anti-NCAM antibody (a kind gift of Dr. C. Goridis) diluted 200-fold in PBS, washed several times and further incubated with peroxydase-linked anti-rabbit IgGs (Amersham) for 1 hr at 37°C. After several washes, peroxydase was revealed with diaminobenzydine (0.2 mg/ml, Sigma) and H,O, (0.03%) in Tris HCI 50 mM, pH 7.8. The reaction was stopped after 5 min by several rinses in water.
Cell viabiliry. Cell survival was assayed by the capacity of live cells to convert soluble MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] into an insoluble dark-blue formazan reaction product. This test was performed according to Denizot and Lang (1986) . Briefly, IO (*l of 1 mg/ml MTT (Merck, France) in PBS-glucose was added to each well containing 0.1 ml of medium and the cells were returned to the incubator. After 2 hr at 37"C, the medium was removed and the dark-blue formazan formed was dissolved by the addition of 100 pl of di-methyl sulfoxyde (DMSO) to each well. The absorbance of the reaction product was read at 570 nm.
PKC activity measurements.
Freshly dissociated rat cortical El6 neurons were treated 45 min in suspension in PBS without calcium/magnesium (GIBCO-BRL) at a density of 2 IO6 cells1200 ~1. After incubation with the appropriate peptide( cells were washed by addition of 1.3 ml of PBS, collected by centrifugation and quickly frozen on dry ice. For assaying PKC activity, cell pellets were resuspended in 2 ml of ice cold homogeneizing buffer: 20 mM Tris-HCI pH 7.4, IO mM 2-mercaptoethanol, 10 ~lul EGTA, 2 mM EDTA, I mM PMSE 0.25 M sucrose, and 0.3% Triton X-100, and homogenized at 0°C. PKC was assaved bv measuring the incorooration of j2P from ATP into MBPC 14 according to Sasaiuri et al. i1993 ) with modifications. Briefly, the incubation mixture (200 ~1) contained 20 mM Tris-HCl buffer pH 7.5, 0.5 mM MgCl,, 10 )LM MBP,-,,, 50 pg/ml phosphatidyl serine, 5 kg/ ml dioleine, 10 PM ATP, Y-~~P ATP 1Oh dpm, and 50 p,l of the cell fraction. After incubation at 30°C for 10 min. the reaction was stopped by the addition of 3 ml of 20% trichloroactetic acid (TCA). Acid precipitable materials were collected on Whatman GF/C filters and extensively washed with ice-cold 20% TCA. The radioactivity on the filters was measured using a scintillation counter. PKC activity was corrected for nonspecific activity by assaying in the absence of CaCl, with 1 mM EGTA. Results are expressed as pmoles of szP incorporated into MBP,,J min/mg protein.
jzP Labeling of cellular proteins, two dimensional gel electrophoresis, two-dimensional peptide mapping.
As previously described (Araujo et al., 1993) , 3 week old primary cult&es of mouse astrocytes were labeled for 4 hr with 0.15 mCi of 32POa+ in 250 r*l of uhosohatefree medium. After two-dimensional-PAGE (pH 6-4.3 iso&ect;ic focusing gels followed by 13% polyacrylamide gels) ZzP-labeled isoforms of PEA-l& Pa, and Pb spots, were excised from two-dimensional gels and treated with thermolysin (100 pg/ml) at 37°C for 18 hr. The digests solubilized from the gel pieces were lyophilized, dissolved in 10 ~1 of electrophoresis buffer (10% acetic acid, 1% pyridine, pH 3.5) and applied on a cellulose-coated thin layer plate (20 X 20 cm). Electrophoresis was carried out at 350 V for l-2 hr, and the plate then subjected to chromatography with pyridine/butanol/acetic acid/water (37.5:25:7.5:30, by volume). After drying, plates were subjected to autoradiography.
Video time lapse recording. Dissociated neurons of rat embryonic cortex (E15) were plated on the surface of coverslip dishes coated with polyornithine as previously described (Lafont et al., 1993) . After 24 hr. the culture dishes were transfered on the stage of an inverted microscope (Zeiss Axiovert 135) and kept inside an incubator chamber (Cultimat) which maintained the temperature at 37°C. The incubator also maintained the pH of the medium by means of a stream of humidified and warm CO, (4%). An infrared filter and a shutter (Uniblitz) were inserted in the light path. Fibers were observed using a 40X phase contrast objective, and in some cases the image was further magnified using the 1.6X Optovar system of the microscope. Images were obtained with a Newvicon camera (Dage 70). and were further processed (Quantel). A computer controled the shutter opening and the image processor. Images were acquired at 60 set intervals, and were stored on the computer hard disk. Growth cones were recorded for IO-30 min before adding the coupled V-PKCi or the uncoupled V+PKCi peptide mix. An aliquot diluted in 100 pl of culture medium was added to the culture (final concentration: 0.5 pM) and recording was continued for 30 min.
Results

Internalization
of a vector-coupled PKCi peptide (V-PKCi) into live cells pAntp43.58, a peptide identical to the third helix of the homeodomain of Antennapedia translocates through biological membranes (Derossi et al., 1994) . We decided to use this sequence as a vector for the intracellular addressing of a Protein kinase C inhibitor (PKCi) corresponding to PKC pseudosubstrate [Ala,,] PKG,,, described by House and Kemp (1990) . In order to be able to generate a disulfide bond between pAntp43.58 and PKCi, a NPyS-cysteinyl residue was added to the N-terminal sequence of both peptides.
Coupling of the PKCi peptide to the pAntp43~5x vector was performed by reduction of the thiol group on the PKCi peptide using TCEP in a molar l/l ratio, followed by incubation with the NPyS-pAntp.,,~,x peptide (see Material and Methods for a . This prevents the homodimerisation of pAntp,, 5R peptides, and leads preferentially to the formation of heterodimers. The reaction is schematized in Figure IA and the structure of the resulting coupled product, referred to in the entire text as vector-PKCi (V-PKCi), is described in Figure 1B . Coupling was monitored by SDS-PAGE, and the coupled peptide was purified by HPLC. In all cases, coupling of the PKCi peptide to the pAntp43.58 vector yields above 50% of coupled product (V-PKCi, Fig. IC, lane a) . Treating V-PKCi with DTT quantitatively uncouples the heterodimer (Fig. lC, lane b) .
To follow its translocation through cytoplasmic membranes, the PKCi peptide was biotinylated and then coupled to the unlabeled vector. Primary neuronal cell cultures were incubated with biotinylated V-PKCi at 1.5 p,M for 1 hr at 37°C washed and fixed. The biotinylated peptide was then detected using streptavidin-FITC. Figure 2 shows that biotinylated PKCi is present in all cells ( Fig. 2A) . The use of confocal microscopy establishes that the peptide is actually within the cells and in all compartments, including cell body and neurites ( Fig. 2A) . Internalization of PKCi is dependent on its linkage to the vector since it is abolished by a brief treatment with disulfide bond reducing agents (Fig. 2B) . Before assaying the biological activity of V-PKCi in live cells, toxicity test were performed in primary neuron cultures after treatment with V-PKCi. Toxicity was monitored by comparing the mitochondrial activity (MTT test; see Material and Methods) in cells treated or not with V-PKCi at concentrations up to 2 PM (I kg/l00 ~1; IO5 cells per well). Results in Figure 3A demonstrate that a 2 hr incubation has no effect on cell survival at any of the tested concentrations.
Survival of V-PKCi treated cells was also measured in a protocol including a 2 hr incubation followed by 48 hr of recovery in V-PKCi free medium. In the latter conditions, a slight toxicity could be seen at the highest concentration (2 FM) but not at concentrations of up to 1 @M (Fig. 3B) . Therefore, all experiments described below were performed at a nontoxic concentration of 0.5 FM (300 ~1 and IO5 cells per well) of coupled V-PKCi peptide.
V-PKCi peptide is (I spec$c inhibitor of PKC in live neurons and astrocytes
The PKCi peptide, in the micromolar range, has been shown to inhibit specifically the phosphorylation of PKC sites in vitro or in permeabilized cells. We tested whether, at an extracellular concentration of 0. PKC in the presence of y-j'P ATI? PKC activity was determined by measuring the incorporation of j2P in TCA precipitable proteins.
In the absence of PMA, PKC activity is essentially cytosolic. When compared to that observed with the uncoupled peptide, basal PKC activity is inhibited by about 50% following a 45 min incubation with V-PKCi (Fig. 4) . Addition of PMA (I FM) activates PKC and provokes its translocation from the cytoplasm to the membrane. In the latter condition, preincubation with V-PKCi leads to a 1 O-fold decrease in total PKC activity, mainly affecting the membrane-associated activity. The synthetic autoinhibitory domain PKC,, I, peptide (PKCi), in addition to its known ability to inhibit PKC activity strongly in vitro (IC,,, < I PM), also inhibits the Calcium/Calmodulindependent protein kinase II (CaMK-II), although at a much higher concentration (IC,,, = 30 PM) (Smith et al., 1990) . To test the kinase-selectivity of V-PKCi in intact cells, we assayed its effect on the phosphorylation of PEA-15, an endogenous substrate for both CaMK-II and PKC (Araujo et al., 1993; Danziger et al., 1995) . PEA-15 is highly enriched in astrocytes and exists under an unphosphorylated form and two phosphorylated forms: Pa (phosphorylation on Ser,,, by CaMK-II) and Pb which derives from Pa by an additional PKC-dependent phosphorylation on Ser,,, (Chneiweiss et al., unpublished observations). Astrocytes were labeled with z2P phosphate, treated for 30 min with coupled or uncoupled (control) V-PKCi with or without 100 nM PMA, and phosphopeptide mapping of Pb was performed (Fig. 5) . When compared to the control, V-PKCi strongly decreased the level of phosphorylation of the PKC sites (arrowheads) even in the presence of PMA. In contrast, the level of phosphorylation of the CamK-II site (arrow) was not affected by V-PKCi treatment, thus demonstrating that V-PKCi at 0.5 pM could be used as a specific ex vivo PKC inhibitor.
V-PKCi provokes a strong modijcation in growth cone morpholog) Dissociated embryonic (E15) rat cortical neurons were plated on polyornithine-coated glass coverslips and grown in serumfree medium. After 48 hr, when well-developed neurites and distinct growth cones are visible, the cells were incubated with the inhibitory peptide at a concentration of 0.5 p+M. The effect of V-PKCi was first assayed using video time lapse recording. Fields were selected for the presence of a growth cone actively growing for at least IO min before treatment. The addition of PMA V-PKCi Figure 5 . Two-dimensional peptide mapping of PEAl5. The Pb form of PEA-15 was cut out from 2D-PAGE gels performed with homogenates from 32P-labeled astrocytes. Labeled phosphoprotein (500-1500 cpm, Cerenkov counting) was subjected to thertnolysin digestion and analyzed on chromatographic plates. The open circles indicate the origin where the thermolysin digest was applied. Open arrowheads indicate the peptide containing the CaMK-II site, whereas bold arrowheads point to the two peptides containing the seryl residue phosphorylated by PKC. the uncoupled mixture of PKCi and vector (control), did not affect growth cone activity (Fig. 6A) . In contrast, V-PKCi induced a dramatic morphological modification characterized by a rapid (within 3 min) retraction of the filopodes (Fig. 6&C) . This phenomenon was in many cases followed by a retraction of the intra-shaft material, leaving a phantom of membranous material on the substrate, often seen in collapsing neurites (Fig.   6C) .
A statistical morphometric analysis allowed us to analyze the effect of V-PKCi at the level of the entire population of growth cones present in the culture. Cells were plated at low density (104 cells/24 plate well), grown for 48 hr, treated with coupled or uncoupled V-PKCi (0.5 pM) or with V-PKCc. PKCc differs from PKCi by 1 amino acid and presents no inhibitory activity (House and kemp, 1990) . After different periods of time, cells were fixed and immunolabeled for N-CAM to facilitate the detection of growth cones and the analysis of their shape. In each condition, 50 neurons were randomly chosen and the surface of the growth cone was measured using the IMSTAR software. Since uncoupling of V-PK6i is achieved by adding DTT (1 ItIM) to the concentrated peptide solution, thereby leading to the presence of 6 nM Dl'T in the cultures, we verified that this concentration of D'lT had no effect on the growth cone surface (Fig.  7A) . Figure 7B illustrates the percentage distributions according to growth cone surfaces between cells treated for different periods of time (10, 30, and 120 min) with coupled or uncoupled V-PKCi at the same molarity. As demonstrated in Figure 7 , C and D, the internalization of PKCc, a peptide devoid of inhibitory activity has no effect on growth cone morphology. Identical results were observed when neurons were grown on a different substratum, in particular polyomithine-laminin instead of polyomithine (data not shown).
Discussion
In this study we have used a newly discovered system of vectorization to introduce the PKC pseudosubstrate sequence into the cytoplasmic compartment of live cells. We demonstrate that linkage of PKCi to the vector allows its internalization, resulting in specific inhibition of PKC and growth cone collapse.
Definition of the vector peptide
The vector peptide was designed following the finding that the 60 amino-acid-long homeodomain of the transcription factor Antennapedia could translocate through biological membranes (Jo- , 199la; Bloch-Gallego et al., 1993) . Translocation which also occurs at 4°C and thus does not depend on classical endocytosis, was exploited to internalize oligonucleotides (Allinquant et al., 1995) or fusion proteins composed of the entire homeodomain and of various peptidic sequences (Perez et al., 1992 (Perez et al., , 1994 .
Site-directed mutagenesis of pAntp (Le Roux et al., 1993 ) allowed to define a smaller peptide, pAntp,, 5x, that retains pAntp internalization properties. This peptide, corresponding to the 16 amino-acid-long third helix of the homeodomain, indeed translocates through biological membranes at both 4°C and 37°C (Derossi et al., 1994) . We thus decided to investigate whether the third helix of the homeodomain could be used to introduce bioactive compounds inside live cells, in particular oligonucleotides (Troy et al., 1994) and oligopeptides (this study).
Internulization of PKCi
The lack of specific PKC inhibitors capable of crossing biological membranes and/or devoid of secondary effects renders previous results on the role of PKC in neurite elongation rather circumstantial. Therefore, we have decided to internalize the PKC peptidic pseudosubstrate, a small peptide (I 3 amino acids), presenting a highly specific biological activity.
Internalization of the PKCi requires its covalent linkage to the vector peptide through a disulfide bridge. This bridge is not stable within the cells, because of the reductive properties of the cell cytoplasm (presence of glutathion). The half-life of disullide bonds between the homeodomain peptide and another compound is approximately 60 min (unpublished results). The mode of internalization of the vector is not known. The homeodomain and its third helix translocate through the plasma membrane of different cell types, including neurons, tibroblasts, anterior pituitary cells, muscle cells, astrocytes, macrophages, lymphocytes, and oligodendrocytes (Joliot et al., 1991 a; Perez et al., 1992 Perez et al., , 1994 and unpublished results) . Internalization is enhanced by the presence of polysialic acid (PSA) present on immature neuronal cell adhesion molecule (Joliot et al., I99 I b) . In spite of the enhancing effect of PSA, translocation per se is not receptor dependent, since it occurs at 4°C (Joliot et al., 1991 b; Derossi et al., 1994) and since a peptide vector composed of D-amino acids is also internalized (D. Derossi, S. Calvet, A. Prochiantz, A. Brunissen, and G. Chassaing, unpublished observations) .
Whatever the exact mechanism of translocation, it is important to stress that, because internalization of pAntp41~58 does not depend on classical endocytosis, the linked peptide does not travel through endosomal and lysosomal compartments. Consequently, its resistance to proteolytic degradation and general activity in most cellular compartments are enhanced.
Protein kinuse C inhibition
In the absence of stimulation by the phorbol ester PMA, PKC is primarily cytosolic and its inhibition by the internalized PKCi is only 50%. Interestingly, the association of PKC with membranes, provoked by the addition of PMA (which also stimulates the activity) allows an almost complete inhibition by the internalized inhibitor. Although we have no direct explanation for this phenomenon, we propose that enhanced inhibition upon PMA treatment is primarily due to the demasking of the catalytic site (normally occupied by the N-terminus of the enzyme), making it accessible for the exogenous inhibitory peptide.
The total inhibition of PKC activity demonstrates that the internalized peptide inhibits all PKC isoforms present in embryonic cortical neurons. Because of this strong effect, it was important to determine whether the amount of peptide internalized was not interfering with other kinases, in particular CaMK-II, which can be inhibited in vitro by the PKCi pseudosubstrate at concentrations above 30 p,M (Smith et al., 1990) . By following the pattern of phosphorylation of PEA-15, a protein enriched in astrocytes with both PKC and CaMK-II target sites, we showed that in the micromolar (extracellular) range used in our study, the effect of the internalized PKCi is specific for PKC phosphorylation sites.
Growth cone morphology
The addition of V-PKCi on neurons provoked a rapid retraction of the filopodes and lamellipodes. At the same time, the core of the growth cone became globular and increased in size. This process occured within 3 min suggesting an action of PKCi directly at the level of the cone. Such an immediate effect requires that the peptide be internalized very efficiently, reaching rapidly a concentration sufficient to inhibit PKC in the growth cones. This is in agreement with our previous results showing that 20% of homeodomain peptides present in the culture medium are internalized within 2 hr (Le Roux et al., 1993) .
In many occasions we observed a retraction of a dense material present in the distal region of the neurite shaft, with some membranous structures remaining intact. Filopode retraction and withdrawal of the intracellular material at the level of the growth cone suggest that the action of PKC occurs through the modification of the cytoskeleton, very likely at the level of actin and tubulin polymerization. Interestingly, a maximal effect was observed after IO min with no further change in the apparent morphology of the growth cone occuring between 10 min and 2 hr. The latter effects differed from those observed with staurosporine or H7, two other PKC inhibitors which, in addition to provoking growth cone collapse, had profound and slowly developing effects on the general morphology of the cells (not shown).
Interpretutions and further experiments
In the literature, the evidence that PKCs play a role in growth cone shape and motility is primarily based on the use of lipophilic inhibitors or on the desensitization of the enzymes by the addition of high concentrations of phorbol-ester. The latter protocols, although suggestive of a role for PKC in the motility of neuronal growth cones, suffer from the pleiotropic effects of the drugs on neuronal physiology. We thus believe that the use of the vector peptide to internalize the PKC pseudosubstrate in neurons in culture is a technical breakthrough, strongly suggesting that PKC is a key regulator of growth cone morphology. This strategy could be used to internalize several other substances into the nerve terminal, thus providing a very useful approach in the field of neuropharmacology. The observation that inhibiting PKCs provokes a collapse of all growth cones is interesting because these enzymes may provide a site of integration for several transducing events leading to distinct modifications of the cytoskeleton, for example, actin severing (Fan et al., 1993; Neely and Gresemann, 1994) . The presence of PKC isoforms in the growth cones has been reported (Campenot et al., 1994) , including that of PKCE, a calciumindependent isoform and possible target of thrombin-induced remodeling (Suidan et al., 1992) .
Recent reports indeed underscore the role of dynamic remodeling of cytoskeletal components, neurofilaments, microtubules, and actin, on neuronal pathfinding decisions (Fan et al., 1993; Lafont et al., 1993; Lin and Forscher, 1993; Lafont and Prochiantz, 1994; Tanaka et al., 1995) . In this context, it is interesting to note that some PKC targets should modify the state of polymerization of the cytoskeleton or its anchoring to the cellular membranes. Among these targets are proteins that regulate tubulin polymerization such as Dynamin, a GTPase localized in nerve terminals (Robinson et al., 1993) or MAP2 and Tau, two microtubule associated proteins involved in the elongation of dendrites and axons, respectively (Caceres et al., 1991; Correas et al., 1992; Ainsztein and Purich, 1994; Lafont and Prochiantz, 1994) .
Other targets of interest are two major PKC substrates, MARCKS (myristoylated alanine-rich C-kinase substrate), and the growth associated protein GAP43 (Aderem. 1992 : Meiri et al., 1986 . A role for GAP-43 in axonal elongation has been demonstrated (Shea et al., 1991; Baetge et al., 1992) . In addition, it has been shown that phosphorylation of Ser,, in GAP-43 by PKC is necessary for activity (Widmer and Caroni, 1993) . Both MARCKS and GAP43 (Meiri and Gordon-Weeks, 1990) can associate with cytoskeletal components in particular with actin filaments (Lin and Forscher, 1993) , and with a complex containing tubulin and actin together with fodrin, talin and a-actinin, respectively (Meiri and Gordon-Weeks, 1990) .
The aim of this study was limited to testing, using a newly developed technology, whether PKC enzymes are involved in growth cone physiology. It is now necessary to identify PKC targets present in the cones and to analyze how the degree of phosphorylation of these targets correlates with their biological activity at the molecular level and at a more integrated level. For this latter objective, one needs to design compounds capable of interfering specifically with distinct sites of the many components of the growth cone machinery and to introduce them into the cell. Approaches similar to that presented here should prove useful in this perspective. 
References
